Albert Labs

Vancouver, Canada

Albert Labs is a pharmaceutical drug development company pursuing regulatory approval for active compounds to treat mental health.

$605K raised

Mar 2023

Post-IPO Debt

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Albert Labs raised?

Albert Labs has raised $605K in total funding. The most recent round was Post-IPO Debt. The last funding was announced in March 2023.

Who are Albert Labs's investors?

Albert Labs's investors include Cantheon Capital.

Where is Albert Labs headquartered?

Albert Labs is headquartered in Vancouver, Canada.

What does Albert Labs do?

Albert Labs is a pharmaceutical drug development company pursuing regulatory approval for active compounds to treat mental health.

What stage is Albert Labs at?

Albert Labs is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 23, 2023.

MLA

"Albert Labs — Funding & Investors." VCBacked, March 23, 2023, https://www.vcbacked.co/company/albert-labs. Accessed July 2, 2026.

APA

VCBacked. (2023). Albert Labs — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/albert-labs

Wikipedia (cite web)

{{cite web |title=Albert Labs — Funding & Investors |url=https://www.vcbacked.co/company/albert-labs |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 23, 2023.